🔴 4DMedical is trading 10.79% down with no confirmed catalyst identified

4DMedical is trading at A$2.15, down 10.79%, with no confirmed catalyst identified for the November 4 decline.

• 4DMedical previously told the ASX it knew of no undisclosed information and cited increased short interest as a possible explanation.
• Reporting described renewed short-selling after the AGM amid investor divisions over proposed executive bonuses, but did not establish this as the cause of November 4’s fall.
• The ASX 200 fell 0.59%, and 4DMedical was among the session’s biggest losers.